▶ 調査レポート

医薬品用ガラスアンプルの世界市場:製品別

• 英文タイトル:Pharmaceutical Glass Ampoules Market (Product: Straight Stem, Open Funnel, Closed Funnel, and Others; and Capacity: Up to 2ml, 3ml to 5ml, 6ml to 8ml, and Above 8ml) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。医薬品用ガラスアンプルの世界市場:製品別 / Pharmaceutical Glass Ampoules Market (Product: Straight Stem, Open Funnel, Closed Funnel, and Others; and Capacity: Up to 2ml, 3ml to 5ml, 6ml to 8ml, and Above 8ml) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / TPM-2JN009資料のイメージです。• レポートコード:TPM-2JN009
• 出版社/出版日:Transparency Market Research / 2019年12月30日
• レポート形態:英文、PDF、205ページ
• 納品方法:Eメール
• 産業分類:医療装置
• 販売価格(消費税別)
  Single User¥608,475 (USD5,795)▷ お問い合わせ
  Multi User¥923,475 (USD8,795)▷ お問い合わせ
  Corporate License¥1,238,475 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは医薬品用ガラスアンプルの世界市場について調査・分析し、エグゼクティブサマリー、序論、市場動向、地域別(北米、中南米、欧州、アジア太平洋、中東、アフリカ)分析、市場構造分析、競争状況、仮定・アクロニム、研究方法などを含め、次の構成でお届けいたします。
・エグゼクティブサマリー
・序論
・市場動向
・医薬品用ガラスアンプルの世界市場分析・予測
・医薬品用ガラスアンプルの北米市場分析・予測
・医薬品用ガラスアンプルの中南米市場分析・予測
・医薬品用ガラスアンプルの欧州市場分析・予測
・医薬品用ガラスアンプルのアジア太平洋市場分析・予測
・医薬品用ガラスアンプルの中東市場分析・予測
・医薬品用ガラスアンプルのアフリカ市場分析・予測
・市場構造分析
・競争状況
・仮定・アクロニム
・研究方法

Pharmaceutical packaging processes have witnessed innovations in the past decade. Companies engaged in pharmaceutical packaging are increasingly focusing on minimizing errors to ensure that correct and defect-free medicine reaches consumers. Pharmaceutical glass ampoules are extensively used in pharmaceutical and chemical laboratories to preserve and store medicinal fluids, capsules, and liquids that are deployed in a range of pharmaceutical applications. Pharmaceutical glass ampoules are predominantly used to prevent contamination and mix of medicines, and have influenced the shelf life of products.

Pharmaceutical glass ampoules find a range of applications in pharmaceuticals, diagnostics, retail industry, spa items, first aid, cosmetics, dental, toiletries, store hygroscopic materials, and air-sensitive reagents. Pharmaceutical glass ampoules have been widely used to package injectable drugs for several decades and the trend is set to continue during the forecast period (2019-2027). Thus, the pharmaceutical glass ampoules market is expected to reach a value of ~US$ 4 Bn by the end of 2027. The demand for pharmaceutical glass ampoules is witnessing a notable growth in developing regions such as Latin America, Asia Pacific, and Eastern Europe. The growing adoption of pharmaceutical glass ampoules in these regions coupled with the efforts to achieve higher yields are some of the leading factors that are expected to drive the global pharmaceutical glass ampoules market during the forecast period.

Glass has garnered the reputation of being a ‘gold standard’ primary packaging material within the pharmaceutical sector. A significant high volume of pharmaceutical formulations is packaged and stored in pharmaceutical glass ampoules. The pharmaceutical glass ampoules market is witnessing significant growth, as the inorganic nature of glass makes it highly resistant to chemicals and reactive substances. Glass ampoules play an imperative role in protecting the integrity of the drug and prevent it from contamination. Furthermore, as glass ampoules are available in a range of shapes and sizes, their applications continue to expand. At present, several players operating in the glass pharmaceutical glass ampoules market are manufacturing customized glass ampoules to cater to the swelling demand from various end-use industries.

In terms of product, straight stem and open funnel glass ampoules are expected to witness an increase in demand during the forecast period. With just over 10,098 million units sold worldwide, the straight stem product segment accounted for a share of ~33% of the pharmaceutical glass ampoule market in 2018, in terms of volume. This segment is projected to account for a share of ~36% of the pharmaceutical glass ampoule market in 2027, as manufacturers are deploying advanced technologies and cutting-edge manufacturing processes to enhance their production capacities and improve product quality. For instance, several companies operating in the pharmaceutical glass ampoules market are increasing their manufacturing capabilities by launching high-speed filling lines to improve the functionalities of glass ampoules. Several other participants in the current pharmaceutical glass ampoule market are developing glass ampoules with highly stable dimensional qualities by leveraging the progress in the new filling line technology.

レポート目次

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. TMR Analysis and Recommendations

2. Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

3. Pharmaceutical Glass Ampoules Market Overview

3.1. Global GDP Outlook

3.2. Health Spending outlook

3.3. Global Healthcare Expenditure

3.4. Global Packaging Industry Outlook

3.5. Global Pharmaceutical Glass Packaging Market Outlook

3.6. Global Parenteral Packaging Market Outlook

3.7. Macroeconomic Indicators

3.7.1. GDP Growth

3.7.2. Per Capita Healthcare Expenditure Growth

3.7.3. Packaging Industry Growth

3.7.4. Pharmaceutical Industry Growth

3.7.5. Glass Packaging Industry Growth

3.7.6. Pharmaceutical Packaging Industry Growth

3.8. Forecast Factors: Relevance and Impact

3.9. Value Chain

3.9.1. Key Market Participants

3.9.1.1. Raw Material Suppliers

3.9.1.2. Pharmaceutical Glass Ampoules Manufacturers

3.9.1.3. Distributors/Suppliers

3.9.1.4. End-users

3.9.2. Profitability Margin

3.10. Market Dynamics

3.10.1. Drivers

3.10.1.1. Supply-side

3.10.1.2. Demand-side

3.10.2. Restraints

3.10.3. Trends

3.11. Pharmaceutical Glass Ampoules Production, by company

4. Global Pharmaceutical Glass Ampoules Market Analysis and Forecast

4.1. Introduction

4.2. Export and Import of Glass Ampoules, by Key Countries in Value (US$ Thousand) and Volume (Tonnes)

4.3. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Region

4.3.1. North America

4.3.2. Latin America

4.3.3. Europe

4.3.4. Asia Pacific

4.3.5. Middle East

4.3.6. Africa

4.4. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Product Type

4.4.1. Straight Stem

4.4.2. Open Funnel

4.4.3. Closed Funnel

4.4.4. Others (Double Tip, etc.)

4.5. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Capacity

4.5.1. Up to 2 ml

4.5.2. 3 to 5 ml

4.5.3. 6 to 8 ml

4.5.4. Above 8 ml

4.6. Market Attractiveness Analysis

5. North America Pharmaceutical Glass Ampoules Market Analysis and Forecast

5.1. Introduction

5.2. Export and Import of Glass Ampoules, by Key Countries in Value (US$ Thousand) and Volume (Tonnes)

5.3. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Country

5.3.1. U.S.

5.3.2. Canada

5.4. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Product Type

5.4.1. Straight Stem

5.4.2. Open Funnel

5.4.3. Closed Funnel

5.4.4. Others (Double Tip, etc.)

5.5. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Capacity

5.5.1. Up to 2 ml

5.5.2. 3 to 5 ml

5.5.3. 6 to 8 ml

5.5.4. Above 8 ml

5.6. Market Attractiveness Analysis

6. Latin America Pharmaceutical Glass Ampoules Market Analysis and Forecast

6.1. Introduction

6.2. Export and Import of Glass Ampoules, by Key Countries in Value (US$ Thousand) and Volume (Tonnes)

6.3. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Country

6.3.1. Brazil

6.3.2. Mexico

6.3.3. Rest of Latin America

6.4. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Product Type

6.4.1. Straight Stem

6.4.2. Open Funnel

6.4.3. Closed Funnel

6.4.4. Others (Double Tip, etc.)

6.5. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Capacity

6.5.1. Up to 2 ml

6.5.2. 3 to 5 ml

6.5.3. 6 to 8 ml

6.5.4. Above 8 ml

6.6. Market Attractiveness Analysis

7. Europe Pharmaceutical Glass Ampoules Market Analysis and Forecast

7.1. Introduction

7.2. Export and Import of Glass Ampoules, by Key Countries in Value (US$ Mn) and Volume (Tonnes)

7.3. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Country

7.3.1. Germany

7.3.2. Spain

7.3.3. Italy

7.3.4. France

7.3.5. U.K.

7.3.6. BENELUX

7.3.7. Nordics

7.3.8. Russia

7.3.9. Poland

7.3.10. Rest of Europe

7.4. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Product Type

7.4.1. Straight Stem

7.4.2. Open Funnel

7.4.3. Closed Funnel

7.4.4. Others (Double Tip, etc.)

7.5. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Capacity

7.5.1. Up to 2 ml

7.5.2. 3 to 5 ml

7.5.3. 6 to 8 ml

7.5.4. Above 8 ml

7.6. Market Attractiveness Analysis

8. Asia Pacific Pharmaceutical Glass Ampoules Market Analysis and Forecast

8.1. Introduction

8.2. Export and Import of Glass Ampoules, by Key Countries in Value (US$ Thousand) and Volume (Tonnes)

8.3. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Country

8.3.1. China

8.3.2. India

8.3.3. Japan

8.3.4. South Korea

8.3.5. ASEAN Countries

8.3.6. Australia and New Zealand

8.3.7. Rest of Asia Pacific

8.4. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Product Type

8.4.1. Straight Stem

8.4.2. Open Funnel

8.4.3. Closed Funnel

8.4.4. Others (Double Tip, etc.)

8.5. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Capacity

8.5.1. Up to 2 ml

8.5.2. 3 to 5 ml

8.5.3. 6 to 8 ml

8.5.4. Above 8 ml

8.6. Market Attractiveness Analysis

9. Middle East Pharmaceutical Glass Ampoules Market Analysis and Forecast

9.1. Introduction

9.2. Export and Import of Glass Ampoules, by Key Countries in Value (US$ Mn) and Volume (Tonnes)

9.3. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Country

9.3.1. Turkey

9.3.2. Iran

9.3.3. United Arab Emirates

9.3.4. Saudi Arabia

9.3.5. Cyprus

9.3.6. Israel

9.3.7. Qatar

9.3.8. Rest of Middle East

9.4. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Product Type

9.4.1. Straight Stem

9.4.2. Open Funnel

9.4.3. Closed Funnel

9.4.4. Others (Double Tip, etc.)

9.5. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Capacity

9.5.1. Up to 2 ml

9.5.2. 3 to 5 ml

9.5.3. 6 to 8 ml

9.5.4. Above 8 ml

9.6. Market Attractiveness Analysis

10. Africa Pharmaceutical Glass Ampoules Market Analysis and Forecast

10.1. Introduction

10.2. Export and Import of Glass Ampoules, by Key Countries in Value (US$ Mn) and Volume (Tonnes)

10.3. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Country

10.3.1. South Africa

10.3.2. Egypt

10.3.3. Nigeria

10.3.4. Morocco

10.3.5. Rest of Africa

10.4. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Product Type

10.4.1. Straight Stem

10.4.2. Open Funnel

10.4.3. Closed Funnel

10.4.4. Others (Double Tip, etc.)

10.5. Market Size (US$ Mn) and Volume (Mn Units) Historical 2014-2018 and Forecast 2019-2027, by Capacity

10.5.1. Up to 2 ml

10.5.2. 3 to 5 ml

10.5.3. 6 to 8 ml

10.5.4. Above 8 ml

10.6. Market Attractiveness Analysis

11. Market Structure Analysis

11.1. Market Analysis, by Tier of Companies

11.2. Production Capacity Share Analysis

11.3. Market Presence Analysis

12. Competitive Landscape

12.1. Competition Dashboard

12.2. Competition Benchmarking

12.3. Competition Deep Dive (Glass Ampoules Manufacturers)

12.3.1. AAPL Solutions

12.3.1.1. Overview

12.3.1.2. Product Portfolio

12.3.1.3. SWOT Analysis

12.3.1.4. Production Footprint

12.3.1.5. Sales Footprint

12.3.1.6. Competition Benchmarking

12.3.1.7. Strategy

12.3.1.7.1. Marketing Strategy

12.3.1.7.2. Product Strategy

12.3.1.7.3. Channel Strategy

12.3.2. Accu-Glass LLC.

12.3.2.1. Overview

12.3.2.2. Product Portfolio

12.3.2.3. SWOT Analysis

12.3.2.4. Production Footprint

12.3.2.5. Sales Footprint

12.3.2.6. Competition Benchmarking

12.3.2.7. Strategy

12.3.2.7.1. Marketing Strategy

12.3.2.7.2. Product Strategy

12.3.2.7.3. Channel Strategy

12.3.3. Adit Containers Private Limited

12.3.3.1. Overview

12.3.3.2. Product Portfolio

12.3.3.3. SWOT Analysis

12.3.3.4. Production Footprint

12.3.3.5. Sales Footprint

12.3.3.6. Competition Benchmarking

12.3.3.7. Strategy

12.3.3.7.1. Marketing Strategy

12.3.3.7.2. Product Strategy

12.3.3.7.3. Channel Strategy

12.3.4. Agrado S.A.

12.3.4.1. Overview

12.3.4.2. Product Portfolio

12.3.4.3. SWOT Analysis

12.3.4.4. Production Footprint

12.3.4.5. Sales Footprint

12.3.4.6. Competition Benchmarking

12.3.4.7. Strategy

12.3.4.7.1. Marketing Strategy

12.3.4.7.2. Product Strategy

12.3.4.7.3. Channel Strategy

12.3.5. Amposan S.A.

12.3.5.1. Overview

12.3.5.2. Product Portfolio

12.3.5.3. SWOT Analysis

12.3.5.4. Production Footprint

12.3.5.5. Sales Footprint

12.3.5.6. Competition Benchmarking

12.3.5.7. Strategy

12.3.5.7.1. Marketing Strategy

12.3.5.7.2. Product Strategy

12.3.5.7.3. Channel Strategy

12.3.6. Birgimefar Group

12.3.6.1. Overview

12.3.6.2. Product Portfolio

12.3.6.3. SWOT Analysis

12.3.6.4. Production Footprint

12.3.6.5. Sales Footprint

12.3.6.6. Competition Benchmarking

12.3.6.7. Strategy

12.3.6.7.1. Marketing Strategy

12.3.6.7.2. Product Strategy

12.3.6.7.3. Channel Strategy

12.3.7. Cang Zhou Four-star Glass Co.,Ltd.

12.3.7.1. Overview

12.3.7.2. Product Portfolio

12.3.7.3. SWOT Analysis

12.3.7.4. Production Footprint

12.3.7.5. Sales Footprint

12.3.7.6. Competition Benchmarking

12.3.7.7. Strategy

12.3.7.7.1. Marketing Strategy

12.3.7.7.2. Product Strategy

12.3.7.7.3. Channel Strategy

12.3.8. Corning Pharmaceutical Glass S.p.A. (Corning Inc.)

12.3.8.1. Overview

12.3.8.2. Product Portfolio

12.3.8.3. SWOT Analysis

12.3.8.4. Production Footprint

12.3.8.5. Sales Footprint

12.3.8.6. Competition Benchmarking

12.3.8.7. Strategy

12.3.8.7.1. Marketing Strategy

12.3.8.7.2. Product Strategy

12.3.8.7.3. Channel Strategy

12.3.9. CRESTANI s.r.l.

12.3.9.1. Overview

12.3.9.2. Product Portfolio

12.3.9.3. SWOT Analysis

12.3.9.4. Production Footprint

12.3.9.5. Sales Footprint

12.3.9.6. Competition Benchmarking

12.3.9.7. Strategy

12.3.9.7.1. Marketing Strategy

12.3.9.7.2. Product Strategy

12.3.9.7.3. Channel Strategy

12.3.10. CRIS-MAT S.L.

12.3.10.1. Overview

12.3.10.2. Product Portfolio

12.3.10.3. SWOT Analysis

12.3.10.4. Production Footprint

12.3.10.5. Sales Footprint

12.3.10.6. Competition Benchmarking

12.3.10.7. Strategy

12.3.10.7.1. Marketing Strategy

12.3.10.7.2. Product Strategy

12.3.10.7.3. Channel Strategy

12.3.11. Gerresheimer AG

12.3.11.1. Overview

12.3.11.2. Product Portfolio

12.3.11.3. SWOT Analysis

12.3.11.4. Production Footprint

12.3.11.5. Sales Footprint

12.3.11.6. Competition Benchmarking

12.3.11.7. Strategy

12.3.11.7.1. Marketing Strategy

12.3.11.7.2. Product Strategy

12.3.11.7.3. Channel Strategy

12.3.12. GHANI GLOBAL GLASS LIMITED

12.3.12.1. Overview

12.3.12.2. Product Portfolio

12.3.12.3. SWOT Analysis

12.3.12.4. Production Footprint

12.3.12.5. Sales Footprint

12.3.12.6. Competition Benchmarking

12.3.12.7. Strategy

12.3.12.7.1. Marketing Strategy

12.3.12.7.2. Product Strategy

12.3.12.7.3. Channel Strategy

12.3.13. J. Penner Corporation

12.3.13.1. Overview

12.3.13.2. Product Portfolio

12.3.13.3. SWOT Analysis

12.3.13.4. Production Footprint

12.3.13.5. Sales Footprint

12.3.13.6. Competition Benchmarking

12.3.13.7. Strategy

12.3.13.7.1. Marketing Strategy

12.3.13.7.2. Product Strategy

12.3.13.7.3. Channel Strategy

12.3.14. James Alexander Corporation

12.3.14.1. Overview

12.3.14.2. Product Portfolio

12.3.14.3. SWOT Analysis

12.3.14.4. Production Footprint

12.3.14.5. Sales Footprint

12.3.14.6. Competition Benchmarking

12.3.14.7. Strategy

12.3.14.7.1. Marketing Strategy

12.3.14.7.2. Product Strategy

12.3.14.7.3. Channel Strategy

12.3.15. Kapoor Glass India Private Limited

12.3.15.1. Overview

12.3.15.2. Product Portfolio

12.3.15.3. SWOT Analysis

12.3.15.4. Production Footprint

12.3.15.5. Sales Footprint

12.3.15.6. Competition Benchmarking

12.3.15.7. Strategy

12.3.15.7.1. Marketing Strategy

12.3.15.7.2. Product Strategy

12.3.15.7.3. Channel Strategy

12.3.16. Khemka Glass

12.3.16.1. Overview

12.3.16.2. Product Portfolio

12.3.16.3. SWOT Analysis

12.3.16.4. Production Footprint

12.3.16.5. Sales Footprint

12.3.16.6. Competition Benchmarking

12.3.16.7. Strategy

12.3.16.7.1. Marketing Strategy

12.3.16.7.2. Product Strategy

12.3.16.7.3. Channel Strategy

12.3.17. Kishore Group

12.3.17.1. Overview

12.3.17.2. Product Portfolio

12.3.17.3. SWOT Analysis

12.3.17.4. Production Footprint

12.3.17.5. Sales Footprint

12.3.17.6. Competition Benchmarking

12.3.17.7. Strategy

12.3.17.7.1. Marketing Strategy

12.3.17.7.2. Product Strategy

12.3.17.7.3. Channel Strategy

12.3.18. Lutz Packaging GmbH

12.3.18.1. Overview

12.3.18.2. Product Portfolio

12.3.18.3. SWOT Analysis

12.3.18.4. Production Footprint

12.3.18.5. Sales Footprint

12.3.18.6. Competition Benchmarking

12.3.18.7. Strategy

12.3.18.7.1. Marketing Strategy

12.3.18.7.2. Product Strategy

12.3.18.7.3. Channel Strategy

12.3.19. Maruti Industries

12.3.19.1. Overview

12.3.19.2. Product Portfolio

12.3.19.3. SWOT Analysis

12.3.19.4. Production Footprint

12.3.19.5. Sales Footprint

12.3.19.6. Competition Benchmarking

12.3.19.7. Strategy

12.3.19.7.1. Marketing Strategy

12.3.19.7.2. Product Strategy

12.3.19.7.3. Channel Strategy

12.3.20. Métier Ampoules Private Limited

12.3.20.1. Overview

12.3.20.2. Product Portfolio

12.3.20.3. SWOT Analysis

12.3.20.4. Production Footprint

12.3.20.5. Sales Footprint

12.3.20.6. Competition Benchmarking

12.3.20.7. Strategy

12.3.20.7.1. Marketing Strategy

12.3.20.7.2. Product Strategy

12.3.20.7.3. Channel Strategy

12.3.21. Nipro Pharma Packaging International

12.3.21.1. Overview

12.3.21.2. Product Portfolio

12.3.21.3. SWOT Analysis

12.3.21.4. Production Footprint

12.3.21.5. Sales Footprint

12.3.21.6. Competition Benchmarking

12.3.21.7. Strategy

12.3.21.7.1. Marketing Strategy

12.3.21.7.2. Product Strategy

12.3.21.7.3. Channel Strategy

12.3.22. Pharma-Glas GmbH

12.3.22.1. Overview

12.3.22.2. Product Portfolio

12.3.22.3. SWOT Analysis

12.3.22.4. Production Footprint

12.3.22.5. Sales Footprint

12.3.22.6. Competition Benchmarking

12.3.22.7. Strategy

12.3.22.7.1. Marketing Strategy

12.3.22.7.2. Product Strategy

12.3.22.7.3. Channel Strategy

12.3.23. Piramida d.o.o.

12.3.23.1. Overview

12.3.23.2. Product Portfolio

12.3.23.3. SWOT Analysis

12.3.23.4. Production Footprint

12.3.23.5. Sales Footprint

12.3.23.6. Competition Benchmarking

12.3.23.7. Strategy

12.3.23.7.1. Marketing Strategy

12.3.23.7.2. Product Strategy

12.3.23.7.3. Channel Strategy

12.3.24. SCHOTT AG

12.3.24.1. Overview

12.3.24.2. Product Portfolio

12.3.24.3. SWOT Analysis

12.3.24.4. Production Footprint

12.3.24.5. Sales Footprint

12.3.24.6. Competition Benchmarking

12.3.24.7. Strategy

12.3.24.7.1. Marketing Strategy

12.3.24.7.2. Product Strategy

12.3.24.7.3. Channel Strategy

12.3.25. SGD SA

12.3.25.1. Overview

12.3.25.2. Product Portfolio

12.3.25.3. SWOT Analysis

12.3.25.4. Production Footprint

12.3.25.5. Sales Footprint

12.3.25.6. Competition Benchmarking

12.3.25.7. Strategy

12.3.25.7.1. Marketing Strategy

12.3.25.7.2. Product Strategy

12.3.25.7.3. Channel Strategy

12.3.26. Shandong Pharmaceutical Glass Co.,Ltd.

12.3.26.1. Overview

12.3.26.2. Product Portfolio

12.3.26.3. SWOT Analysis

12.3.26.4. Production Footprint

12.3.26.5. Sales Footprint

12.3.26.6. Competition Benchmarking

12.3.26.7. Strategy

12.3.26.7.1. Marketing Strategy

12.3.26.7.2. Product Strategy

12.3.26.7.3. Channel Strategy

12.3.27. SM PACK SpA

12.3.27.1. Overview

12.3.27.2. Product Portfolio

12.3.27.3. SWOT Analysis

12.3.27.4. Production Footprint

12.3.27.5. Sales Footprint

12.3.27.6. Competition Benchmarking

12.3.27.7. Strategy

12.3.27.7.1. Marketing Strategy

12.3.27.7.2. Product Strategy

12.3.27.7.3. Channel Strategy

12.3.28. Stevanato Group

12.3.28.1. Overview

12.3.28.2. Product Portfolio

12.3.28.3. SWOT Analysis

12.3.28.4. Production Footprint

12.3.28.5. Sales Footprint

12.3.28.6. Competition Benchmarking

12.3.28.7. Strategy

12.3.28.7.1. Marketing Strategy

12.3.28.7.2. Product Strategy

12.3.28.7.3. Channel Strategy

12.3.29. Techno Ampoules (Pvt.) Ltd.

12.3.29.1. Overview

12.3.29.2. Product Portfolio

12.3.29.3. SWOT Analysis

12.3.29.4. Production Footprint

12.3.29.5. Sales Footprint

12.3.29.6. Competition Benchmarking

12.3.29.7. Strategy

12.3.29.7.1. Marketing Strategy

12.3.29.7.2. Product Strategy

12.3.29.7.3. Channel Strategy

12.3.30. Tecnoglas, S.A

12.3.30.1. Overview

12.3.30.2. Product Portfolio

12.3.30.3. SWOT Analysis

12.3.30.4. Production Footprint

12.3.30.5. Sales Footprint

12.3.30.6. Competition Benchmarking

12.3.30.7. Strategy

12.3.30.7.1. Marketing Strategy

12.3.30.7.2. Product Strategy

12.3.30.7.3. Channel Strategy

12.3.31. TVORNICA FARMACEUTSKE AMBALAŽE d.o.o.

12.3.31.1. Overview

12.3.31.2. Product Portfolio

12.3.31.3. SWOT Analysis

12.3.31.4. Production Footprint

12.3.31.5. Sales Footprint

12.3.31.6. Competition Benchmarking

12.3.31.7. Strategy

12.3.31.7.1. Marketing Strategy

12.3.31.7.2. Product Strategy

12.3.31.7.3. Channel Strategy

12.3.32. Zhengchuan Pharmaceutical Packaging Co., Ltd.

12.3.32.1. Overview

12.3.32.2. Product Portfolio

12.3.32.3. SWOT Analysis

12.3.32.4. Production Footprint

12.3.32.5. Sales Footprint

12.3.32.6. Competition Benchmarking

12.3.32.7. Strategy

12.3.32.7.1. Marketing Strategy

12.3.32.7.2. Product Strategy

12.3.32.7.3. Channel Strategy

12.4. Competition Deep Dive (Borosilicate Tubes for Ampoules and Vials Manufacturers)

12.4.1. Linuo Glassworks Group

12.4.1.1. Overview

12.4.1.2. Product Portfolio

12.4.1.3. SWOT Analysis

12.4.1.4. Production Footprint

12.4.1.5. Sales Footprint

12.4.1.6. Competition Benchmarking

12.4.1.7. Strategy

12.4.1.7.1. Marketing Strategy

12.4.1.7.2. Product Strategy

12.4.1.7.3. Channel Strategy

12.4.2. Hilgenberg GmbH

12.4.2.1. Product Portfolio

12.4.2.2. SWOT Analysis

12.4.2.3. Production Footprint

12.4.2.4. Sales Footprint

12.4.2.5. Competition Benchmarking

12.4.2.6. Strategy

12.4.2.6.1. Marketing Strategy

12.4.2.6.2. Product Strategy

12.4.2.6.3. Channel Strategy

12.4.3. Linuo Glassworks Group

12.4.3.1. Product Portfolio

12.4.3.2. SWOT Analysis

12.4.3.3. Production Footprint

12.4.3.4. Sales Footprint

12.4.3.5. Competition Benchmarking

12.4.3.6. Strategy

12.4.3.6.1. Marketing Strategy

12.4.3.6.2. Product Strategy

12.4.3.6.3. Channel Strategy

12.4.4. Neubor Glass Srl

12.4.4.1. Product Portfolio

12.4.4.2. SWOT Analysis

12.4.4.3. Production Footprint

12.4.4.4. Sales Footprint

12.4.4.5. Competition Benchmarking

12.4.4.6. Strategy

12.4.4.6.1. Marketing Strategy

12.4.4.6.2. Product Strategy

12.4.4.6.3. Channel Strategy

13. Assumptions & Acronyms

14. Research Methodology

List of Tables

Table 01: Global Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Country

Table 02: Global Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Country

Table 03: Global Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Product Type

Table 04: Global Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Product Type

Table 05: Global Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Capacity

Table 06: Global Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Capacity

Table 07: North America Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Country

Table 08: North America Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Country

Table 09: North America Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Product Type

Table 10: North America Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Product Type

Table 11: North America Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Capacity

Table 12: North America Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Capacity

Table 13: Latin America Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Country

Table 14: Latin America Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Country

Table 15: Latin America Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Product Type

Table 16: Latin America Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Product Type

Table 17: Latin America Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Capacity

Table 18: Latin America Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Capacity

Table 19: Europe Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Country

Table 20: Europe Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Country

Table 21: Europe Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Product Type

Table 22: Europe Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Product Type

Table 23: Europe Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Capacity

Table 24: Europe Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Capacity

Table 25: Asia Pacific Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Country

Table 26: Asia Pacific Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Country

Table 27: Asia Pacific Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Product Type

Table 28: Asia Pacific Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Product Type

Table 29: Asia Pacific Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Capacity

Table 30: Asia Pacific Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Capacity

Table 31: Middle East Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Country

Table 32: Middle East Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Country

Table 33: Middle East Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Product Type

Table 34: Middle East Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Product Type

Table 35: Middle East Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Capacity

Table 36: Middle East Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Capacity

Table 37: Africa Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Country

Table 38: Africa Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Country

Table 39: Africa Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Product Type

Table 40: Africa Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Product Type

Table 41: Africa Pharmaceutical Glass Ampoules Market Volume (Mn Units) Analysis (2014H-2027F) by Capacity

Table 42: Africa Pharmaceutical Glass Ampoules Market Value (US$ Mn) Analysis (2014H-2027F) by Capacity